Category |
Definitions* |
Clinical Application |
| Category A |
"Controlled studies in women fail to demonstrate a risk
to the fetus in the first trimester (and there is no evidence of a risk in later
trimester), and the possibility of fetal harm appears remote." |
For all practical purposes, there are no Category A drugs. |
| Category B |
"Either animal-reproduction studies have not
demonstrated a fetal risk but there are no controlled studies in pregnant women or
animal-reproduction studies have shown an adverse effect (other than a decrease in
fertility) that was not confirmed in controlled studies in women in the first trimester
(and there is no evidence of a risk in later trimesters)." |
Category B drugs include prenatal vitamins, acetaminophen
and several other medications used routinely and safely during pregnancy. If there is a
clinical need for a Category B drug, it is considered safe to use it. |
| Category C |
"Either studies in animals have revealed adverse
effects on the fetus (teratogenic or embryocidal or other) and there are no controlled
studies in women or studies in women and animals are not available. Drugs should be given
only if the potential benefit justifies the potential risk to the fetus." |
Category C drugs have not been shown to be harmful to
fetuses (if they had been, they wouldn't be Category C drugs). However, there are some
reasons to be more concerned about these drugs than Category B drugs. If the pregnant
patient will benefit from a Category C drug, it is generally used, although most
obstetricians would prefer a Category B drug if it will give equivalently good results. |
| Category D |
"There is positive evidence of human fetal risk, but
the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the
drug is needed in a life-threatening situation or for a serious disease for which safer
drugs cannot be used or are ineffective.)" |
Category D drugs have some significant risks. They should be
used during pregnancy only when the alternatives are worse. |
| Category X |
"Studies in animals or human beings have demonstrated
fetal abnormalities or there is evidence of fetal risk based on human experience or both,
and the risk of the use of the drug in pregnant women clearly outweighs any possible
benefit. The drug is contraindicated in women who are or may become pregnant." |
Category X drugs should not be used during pregnancy. |
*Food and Drug Administration. Federal Register 1980;44:37434-67
Approved for public release; Distribution is unlimited.
The listing of any non-Federal product in this CD is not an
endorsement of the product itself, but simply an acknowledgement of the source.
Operational Medicine 2001
Health Care in Military Settings
Bureau of Medicine and
Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational
Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
*This web version is provided by
The Brookside Associates Medical Education
Division. It contains original contents from the official US Navy
NAVMED P-5139, but has been reformatted for web access and includes advertising
and links that were not present in the original version. This web version has
not been approved by the Department of the Navy or the Department of Defense.
The presence of any advertising on these pages does not constitute an
endorsement of that product or service by either the US Department of Defense or
the Brookside Associates. The Brookside Associates is a private organization,
not affiliated with the United States Department of Defense.
Contact Us · · Other
Brookside Products
|
